In our study, the analysis of the CXCR2 expression profile in breast cancer patient tissue biopsies showed that CXCR2 expression is significantly upregulated in patients of the TNBC subtype and other BC subtypes (Figure 1). This evidence concerns the gene CXCR2 and breast carcinoma.